Skip to Content
Merck
  • EZH2-mediated epigenetic repression of DNA repair in promoting breast tumor initiating cells.

EZH2-mediated epigenetic repression of DNA repair in promoting breast tumor initiating cells.

Breast cancer research : BCR (2011-06-16)
Olafur Andri Stefansson, Manel Esteller
ABSTRACT

Members of the Polycomb-group (PcG) family of proteins, including EZH2 (enhancer of zeste homolog 2), are involved in establishing epigenetic silencing of developmental genes in adult and embryonic stem cells, and their deregulation has been implicated in cancer. In a recent report, EZH2-mediated epigenetic repression of DNA damage repair in breast tumor initiating cells (BTICs) was identified as a mechanism that could promote expansion of BTICs, and may contribute to cancer progression.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
RAF1 (EE) (306-end), active, GST tagged human, PRECISIO® Kinase, recombinant, expressed in baculovirus infected Sf9 cells, ≥70% (SDS-PAGE), buffered aqueous glycerol solution